Business

The AI Eye Podcast: GBT Technologies' CTO Discusses qTerm Human Vital Signs Device Features and "New Paradigm" Potential of Multi-Dimensional IC Design Patent

Point Roberts, Washington and Vancouver, British Columbia--(Newsfile Corp. - November 6, 2020)...

articleGetchell Gold Corp.November 6, 20205/company/getchell-gold-corp/news/the-ai-eye-podcast-gbt-technologies-cto-discusses-qterm-human-vital-signs-device-features-and-new-paradigm-potential-of-multi-dimensional-ic-design-patent
The AI Eye Podcast: GBT Technologies' CTO Discusses qTerm Human Vital Signs Device Features and "New Paradigm" Potential of Multi-Dimensional IC Design Patent

About this update from Getchell Gold Corp.

[{"type":"text","content":"The AI Eye Podcast: GBT Technologies' CTO Discusses qTerm Human Vital Signs Device Features and \"New Paradigm\" Potential of Multi-Dimensional IC Design PatentPoint Roberts, Washington and Vancouver, British Columbia--(Newsfile Corp. - November 6, 2020) - Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today's special edition of The AI Eye, watching stock news, deal tracker and advancements in artificial intelligence, featuring an exclusive interview with the CTO of GBT Technologies Inc. (OTC Pink: GTCH).Listen to today's podcast: https://www.investorideas.com/Audio/Podcasts/2020/110320-AI-Eye-GBT-CTO.mp3Hear the Ai Eye on Spotify According to Danny Rittman, CTO of GBT Technologies Inc. (OTC Pink: GTCH), the company elected to release the first version of its AI-powered human vitals device, qTerm with only three of the four originally-planned features included. He explained that this was a decision made to meet the demand brought on by the COVID-19 pandemic. \"Originally, the qTerm device was planned to come out in its first release with four features - body temperature, heart rate, blood pressure and oxygen,\" he said. \"Due to the pandemic, we wanted to push it out faster [to get] something to the market to help with the [COVID-19] virus.\"This first release will feature the ability to easily measure body temperature, blood oxygen level and heart rate - measurements indicative of COVID-19 infection. Rittman explained that this data, with consent from the user, can be aggregated and put toward a worldwide 'thermal map' to alert others about potential health risks.\"This data … will be fed through the medical app to a backend program, which is where we're going to do processing, analytics and with the user's permission, we'll keep their location in,\" he said. \"It can still be anonymous but we'll be able to alert users about \"hot zones\" that have people with symptoms and that could be a health risk.\"In a recent press release explaining the qTerm's completed features, Rittman indicated that GBT planned \"to expand the device further in the future, adding more features and AI capabilities.\"\"On the second release we're going to add the blood pressure feature as well,\" he said.Elsewhere, it was announced that GBT Technologies has received a notice of allowance from the...

More updates from Getchell Gold Corp.